CN103865844B - Bacteroides uniformis L8 and the application in degraded agar-agar or agaropectin oligose - Google Patents
Bacteroides uniformis L8 and the application in degraded agar-agar or agaropectin oligose Download PDFInfo
- Publication number
- CN103865844B CN103865844B CN201410054976.7A CN201410054976A CN103865844B CN 103865844 B CN103865844 B CN 103865844B CN 201410054976 A CN201410054976 A CN 201410054976A CN 103865844 B CN103865844 B CN 103865844B
- Authority
- CN
- China
- Prior art keywords
- agar
- agaropectin oligose
- degraded
- bacteroides uniformis
- substratum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001817 Agar Polymers 0.000 title claims abstract description 99
- 235000010419 agar Nutrition 0.000 title claims abstract description 48
- 241000206672 Gelidium Species 0.000 title claims abstract description 35
- 241000606219 Bacteroides uniformis Species 0.000 title claims description 43
- 239000002609 medium Substances 0.000 claims description 34
- 238000004809 thin layer chromatography Methods 0.000 claims description 16
- 239000008272 agar Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000011218 seed culture Methods 0.000 claims description 11
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 7
- 239000002054 inoculum Substances 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000120 Artificial Saliva Substances 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 229940099352 cholate Drugs 0.000 claims description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 108010028349 saliva Orthana Proteins 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 108010046845 tryptones Proteins 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 230000001580 bacterial effect Effects 0.000 abstract description 10
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 208000008589 Obesity Diseases 0.000 abstract description 4
- 235000020824 obesity Nutrition 0.000 abstract description 4
- 241000606125 Bacteroides Species 0.000 abstract 2
- 239000007788 liquid Substances 0.000 description 35
- 235000015097 nutrients Nutrition 0.000 description 19
- 241000894006 Bacteria Species 0.000 description 12
- 230000015556 catabolic process Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000006731 degradation reaction Methods 0.000 description 11
- 239000002689 soil Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 239000007795 chemical reaction product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- -1 1-phenyl-3-methyl-5-pyrazolones ketone Chemical class 0.000 description 5
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 5
- 235000013406 prebiotics Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000003321 amplification Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 244000005709 gut microbiome Species 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 230000000529 probiotic effect Effects 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 2
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- CTYRPMDGLDAWRQ-UHFFFAOYSA-N phenyl hydrogen sulfate Chemical compound OS(=O)(=O)OC1=CC=CC=C1 CTYRPMDGLDAWRQ-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000000569 multi-angle light scattering Methods 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009288 screen filtration Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a strain new strains--bacteroides uniformis (Bacteroides? uniformis) L8 and the application in degraded agar-agar or agaropectin oligose, molecular weight can be that the agar-agar of 100 ~ 300kDa is degraded to an agaropectin oligose step of going forward side by side and is degraded to D-semi-lactosi by this bacterial strain, or the agaropectin oligose of molecular weight 0.5 ~ 10kDa is finally degraded to D-semi-lactosi, does agaropectin oligose has specificity simultaneously promote Bacteroides? the effect of uniformis growth, thus reach the related indication effect regulating obesity to cause.
Description
(1) technical field
The present invention relates to the degradation bacteria strains of a kind of agar-agar or agaropectin oligose, the particularly application of bacteroides uniformis (Bacteroidesuniformis) L8 in degraded agar-agar or agaropectin oligose.
(2) background technology
Agar-agar is the polysaccharide in a kind of marine red alga source, primarily of (l → 3)-β-D-semi-lactosi (calling G in the following text) and (1 → 4)-3,6-inner ether-α-L-semi-lactosi (calling A in the following text) is alternately formed by connecting, and agar-agar is widely used in food service industry because of its special gel property as foodstuff additive.Agar-agar can obtain the relatively low agaropectin oligose of molecular weight (calling AO in the following text) through enzyme liberating or acid degradation, recent studies have found that agaropectin oligose has the prebiotic effect promoting bifidobacterium growth in enteron aisle.
To live away from home in the gi tract of Healthy People miscellaneous intestinal microflora, be approximately 10
14left and right.Intestinal microflora and being in all the time in dynamic balance state between host and environment, forms one and depends on each other for existence, and the system of restriction mutually, thus when body defenses function is normal, it is useful and harmless to human body.Normal the gut flora has many important physiological functions, as the regulating effect to host's diabetes, hypertension, hyperlipidemia, immunization, toxin expelling effect and antitumor action etc., but once there is alteration of intestinal flora, these normal physiological functions will certainly be upset.
Edible probiotic bacterium can reach the object maintaining gastrointestinal health, and the probiotic bacterium that current China ratifies to use in food has more than 20 to plant, mainly Bacterium lacticum and bifidus bacillus.Research display probiotic bacterium has multiple physiological hygiene function, comprises cellular immunization promoter action, process lactose intolerance, reduces serum cholesterol, regulate human intestinal microflora balance, antianaphylaxis, suppress carcinogenic substance and other harmful microorganisms.
Prebiotics is a kind of dietary supplements, by optionally stimulating the growth of one or more bacteriums with active and produce wholesome effect to host, thus improves host health.Successful prebiotics should be when by upper digestive tract, major part not digested and can ferment by intestinal microflora.The most important thing is that it just stimulates the growth of profitable strain, instead of have the unwanted bacteria of potential pathogenic or corrupt activity.It is generally acknowledged, prebiotics provides " food " to probiotic bacterium, can be decomposed and absorb, promote beneficial bacteria growth and breeding by beneficial bacteria in enteron aisle.
Document (Gauffinetal, PLoSOne, 2012,7 (7): e41079) is reported, BacteroidesuniformisCECT7771 has the effect of metabolism and the immunologic function disorder regulating obesity to cause, and has potential prebiotic effect.Our result of study finds, agaropectin oligose has the effect that specificity promotes Bacteroidesuniformis growth.Therefore, when agaropectin oligose and Bacteroidesuniformis use jointly, agaropectin oligose by promoting the growth of Bacteroidesuniformis, thus can play the related indication effect regulating obesity to cause.
(3) summary of the invention
The object of the invention is to provide a strain new strains--bacteroides uniformis (Bacteroidesuniformis) L8 and the application in degraded agaropectin oligose (AO) or agar-agar (AP).
The technical solution used in the present invention is:
The invention provides a strain new strains--bacteroides uniformis (Bacteroidesuniformis) L8, be preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number is CGMCCNO.8711, preservation date is on January 10th, 2014, preservation address is No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, postcode 100101.
The present invention also provides the application of described bacteroides uniformis L8 in degraded agar-agar or agaropectin oligose, concrete described application method is: the seed liquor obtained after seed culture by bacteroides uniformis L8 is seeded in agar-agar or agaropectin oligose substratum with the inoculum size of volumetric concentration 2 ~ 10%, 25 ~ 42 DEG C of cultivations, thin layer chromatography (TLC) tracing detection to polymerizable raw material degree is reduced to 7(and molecular weight 1098Da) below, realize the degraded of agar-agar or agaropectin oligose;
Described agar medium final concentration consists of: agar-agar 0.5 ~ 1g/L, Tryptones 3g/L, peptone 3g/L, yeast extract 4.5g/L, Saliva Orthana 0.5g/L, No. 3 cholate 0.4g/L, L-cysteine hydrochloride 0.8g/L, protoheme 0.05g/L, 1ml/L tween 80, NaCl4.5g/L, KCl2.5g/L, MgCl
26H
2o4.5g/L, CaCl
26H
2o0.2g/L, KH
2pO
40.4g/L, micro-2ml/L, solvent is distilled water, and pH value is 6.4 ~ 6.5; Described micro-final concentration consists of: MgSO
47H
2o3.0g/L, CaCl
22H
2o0.1g/L, MnCl
24H
2o0.32g/L, FeSO
47H
2o0.1g/L, CoSO
47H
2o0.18g/L, ZnSO
47H
2o0.18g/L, CuSO
45H
2o0.01g/L, NiCl
26H
2o0.092g/L;
Described agaropectin oligose substratum final concentration consists of: replaced by the 1 ~ 50g/L of the agar-agar in agar medium agaropectin oligose, other form same agar medium.
Further, in described agar medium, the concentration of agar-agar is 0.5 ~ 1g/L, and the molecular weight of described agar-agar is 100 ~ 300kDa, and in preferred agar medium, the concentration of agar-agar is 0.8 ~ 1g/L, and the molecular weight of described agar-agar is 100 ~ 300kDa.
Further, in described agaropectin oligose substratum, the concentration of agaropectin oligose is 1 ~ 50g/L, the molecular weight of described agaropectin oligose is 0.5 ~ 10kDa, and in preferred agaropectin oligose substratum, the concentration of agaropectin oligose is 10 ~ 30g/L, and the molecular weight of described agaropectin oligose is 0.5 ~ 10kDa.
Further, the seed liquor that described bacteroides uniformis L8 obtains after seed culture is inoculated with the inoculum size of volume ratio 4% ~ 6%.
Further, described bacteroides uniformis L8 being applied as in degraded agar-agar or agaropectin oligose: (1) slant culture: bacteroides uniformis L8 is seeded to slant medium, cultivates 2 ~ 4 days for 25 ~ 42 DEG C, obtains inclined-plane thalline; Described slant medium is the agar powder adding quality final concentration 1.5% in agaropectin oligose substratum;
(2) seed culture: be seeded to seed culture medium from inclined-plane thalline picking colony, cultivates 2 ~ 4 days for 25 ~ 42 DEG C, obtains seed liquor; Described seed culture medium is with agaropectin oligose substratum;
(3) fermentation culture: seed liquor is seeded in agar-agar or agaropectin oligose substratum with the inoculum size of volume ratio 4% ~ 6%, 25 ~ 42 DEG C of cultivations, thin layer chromatography (TLC) tracing detection to polymerizable raw material degree is reduced to 7(and molecular weight 1098Da) below, realize the degraded of agar-agar or agaropectin oligose.
Compared with prior art, beneficial effect of the present invention is mainly reflected in: the invention provides a strain new strains--bacteroides uniformis (Bacteroidesuniformis) L8, molecular weight can be that the agar-agar of 100 ~ 300kDa is degraded to D-semi-lactosi by this bacterial strain, or the agaropectin oligose of molecular weight 0.5 ~ 10kDa is degraded to D-semi-lactosi, agaropectin oligose (molecular weight is 0.5 ~ 10kDa) has the effect that specificity promotes Bacteroidesuniformis growth simultaneously, thus reaches the related indication effect regulating obesity to cause.
(4) accompanying drawing explanation
Fig. 1 is that TLC detects B.uniformisL8 to the thin-layer chromatogram of the Degradation of AO, Gal:D-semi-lactosi.
Fig. 2 is that HPLC detects B.uniformisL8 degraded AO end product color atlas, and curve 1 is monose standard substance HPLC stratographic analysis figure, Man-seminose, Rha-rhamnosyl, GalA-galacturonic acid, Glc-glucose, Gal-D-semi-lactosi, Xyl-rhamnosyl; Curve 2 is bacteroides uniformis L8 degraded agaropectin oligose 192h fermented liquid HPLC stratographic analysis figure.
Fig. 3 is that TLC detects B.uniformisL8 to the thin-layer chromatogram of the Degradation of AP.
Fig. 4 is that HPLC detects B.uniformisL8 degraded AP end product color atlas, and curve 1 is monose standard substance HPLC stratographic analysis figure, Man-seminose, Rha-rhamnosyl, GalA-galacturonic acid, Glc-glucose, Gal-semi-lactosi, Xyl-rhamnosyl; Curve 2 is bacteroides uniformis L8 degraded agar-agar 192h fermented liquid HPLC stratographic analysis figure.
(5) embodiment
Below in conjunction with specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in this:
The isolation identification of embodiment 1 bacterial strain L8
(1) preparation of agaropectin oligose and molecular weight determination
10g agar-agar to be added in 1L distilled water after (10mg/mL) heating for dissolving, adding the 1mol/LHCl aqueous solution to HCl final concentration is 0.1mol/L, 60 DEG C of heating in water bath for reaction 1h, after reaction terminates, in reaction solution, add 1mol/LNaOH aqueous solution neutralization reaction liquid pH value to 7, then adopt molecular weight cut-off to be after the nanofiltration membrane desalination of 200 ~ 500Da, trapped fluid 50 DEG C of concentrating under reduced pressure evaporates to dryness, obtain agaropectin oligose 8g, be designated as AO.
Get AO 0.1mol/LNa
2sO
4preparation 5mg/ml solution, with TSK-GELG3000PWXL gel chromatographic columns (30cm × 7.8mm), adopt the analysis of HP1260 type high performance liquid chromatograph to measure, moving phase is 0.1mol/LNa
2sO
4the aqueous solution, column temperature 25 DEG C, flow velocity 0.5ml/min, Composition distribution (G1362A, Agilent company of the U.S.) and multiple angle laser light scattering instrument (DOWNHeleos II, Wyatt company of the U.S.) is adopted to detect, molecular weight through measurement AO is the structure of 0.5 ~ 10kDa, AO is G-[A-G]
n(n is positive integer, 1≤n≤31, and G represents D-semi-lactosi, and A represents 3,6-inner ether semi-lactosi).
(2) preparation of substratum
Preparation VI-AO liquid nutrient medium, concrete composition is as follows: AO(molecular weight 0.5 ~ 10kDa) 5g/L, Tryptones 3g/L, peptone 3g/L, yeast extract 4.5g/L, Saliva Orthana 0.5g/L, 3# cholate 0.4g/L, L-cysteine hydrochloride 0.8g/L, protoheme 0.05g/L, tween 80 1ml, NaCl4.5g/L, KCl2.5g/L, MgCl
26H
2o4.5g/L, CaCl
26H
2o0.2g/L, KH
2pO
40.4g/L, micro-2ml/L, solvent is distilled water, and pH value is 6.4 ~ 6.5, and sterilizing is placed on anaerobism workstation.
Trace element final concentration consists of: MgSO
47H
2o3.0g/L, CaCl
22H
2o0.1g/L, MnCl
24H
2o0.32g/L, FeSO
47H
2o0.1g/L, CoSO
47H
2o0.18g/L, ZnSO
47H
2o0.18g/L, CuSO
45H
2o0.01g/L, NiCl
26H
2o0.092g/L.
(3) pre-treatment of ight soil
Get 1 volunteer's fresh excreta, with PBS(pH7.0) be made into 20%(wt/vol) suspension, fully rear the diameter of mixing is the metallic screen filtration of 2mm, removes large food particles, obtains ight soil PBS solution.
(4) inoculation culture
Gained ight soil PBS solution is seeded to VI-AO substratum (inoculation volume final concentration is 2%), and 37 DEG C of Anaerobic culturel 24h carry out preliminary enrichment culture.Nutrient solution is adopted 10 times of dilution method coated plates, dull and stereotyped add final concentration 2wt% agar for VI-AO liquid nutrient medium.After flat board is placed in anaerobism workstation 37 DEG C cultivation 72h, sample for detecting degraded situation after 37 DEG C of cultivation 144h in picking list bacterium colony to VI-AO liquid nutrient medium in anaerobism workstation.
(5) thin layer chromatography (TLC) detects degraded situation
Supernatant 0.2 μ L point sample on silica-gel plate is got after institute's sample thief is centrifugal, using D-semi-lactosi standard substance and reaction 0h sample as reference, be placed in formic acid: propyl carbinol: after water (volume ratio is 6:3:1) developping agent launches, dry up, dry up after infiltrating in orcinol developer (orcinol-sulphuric acid soln), 120 DEG C of heating 3min develop the color.Obtain the positive colony of degradable AO according to TLC result, be designated as bacterial strain L8, Fig. 1 is that TLC detects bacterial strain L8 to the degraded of AO, and after cultivating 48h as can be seen from Figure 1, agaropectin oligose is degraded, and degrades to end product D-semi-lactosi after cultivating 96h.
(6) qualification of degradation bacteria
A, bacterial strain L8 physio-biochemical characteristics
Table 1 bacterial strain L8 biochemical characteristic (wherein-represent negative ,+represent positive)
B, 16SrDNA sequential analysis
The extraction of DNA: bacterial strain L8 step (5) obtained adopts QIAGEN ight soil test kit (Qiagen company, Germany) to extract DNA.
16SrDNA total length increases:
Primer sequence:
27f(5'-CAGAGTTTGATCCTGGCT-3'),
1492r(5'-AGGAGGTGATCCAGCCGCA-3')
Amplification system: reaction system 25 μ L, DNA profiling 100ng, 10 × PCRBuffer2.5 μ L, dNTPmix (10Mmeach) 0.5 μ L, 10 μMs of each 0.5 μ L of upstream and downstream primer, Taq enzyme (5U/ μ L) 0.2 μ L, adds deionized water and complements to 25 μ L.
Amplification condition: denaturation 94 DEG C of 5min, circulate 94 DEG C of 35S, 55 DEG C of 35S, 72 DEG C of 1min, 35 circulations, extends 8min.
Sheng Gong biotechnology company limited (Shanghai is delivered to after PCR primer purifying, China) carry out DNA sequencing (shown in SEQIDNO:1), sequencing result is submitted in ncbi database and carry out Blast comparison, comparison result shows this bacterial strain and B.uniformis homology is 99%, according to physio-biochemical characteristics and 16SrDNA sequence alignment, bacterial strain L8 is accredited as bacteroides uniformis (B.uniformis), called after bacteroides uniformis (B.uniformis) L8.
SEQIDNO:1 sequence is:
CAGCATGAACTTAGCTTGCTAAGTTTGATGGCGACCGGCGCACGGGTGAGTAACACGTATCCAACCTGCCGATGACTCGGGGATAGCCTTTCGAAAGAAAGATTAATACCCGATGGCATAATTCTTCCGCATGGTAGAACTATTAAAGAATTTCGGTCATCGATGGGGATGCGTTCCATTAGGTTGTTGGCGGGGTAACGGCCCACCAAGCCTTCGATGGATAGGGGTTCTGAGAGGAAGGTCCCCCACATTGGAACTGAGACACGGTCCAAACTCCTACGGGAGGCAGCAGTGAGGAATATTGGTCAATGGACGAGAGTCTGAACCAGCCAAGTAGCGTGAAGGATGACTGCCCTATGGGTTGTAAACTTCTTTTATACGGGAATAAAGTGAGGCACGTGTGCCTTTTTGTATGTACCGTATGAATAAGGATCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGATCCGAGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCGGACGCTTAAGTCAGTTGTGAAAGTTTGCGGCTCAACCGTAAAATTGCAGTTGATACTGGGTGTCTTGAGTACAGTAGAGGCAGGCGGAATTCGTGGTGTAGCGGTGAAATGCTTAGATATCACGAAGAACTCCGATTGCGAAGGCAGCTTGCTGGACTGTAACTGACGCTGATGCTCGAAAGTGTGGGTATCAAACAGGATTAGATACCCTGGTAGTCCACACAGTAAACGATGAATACTCGCTGTTTGCGATATACAGTAAGCGGCCAAGCGAAAGCGTTAAGTATTCCACCTGGGGAGTACGCCGGCAACGGTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGAGGAACATGTGGTTTAATTCGATGATACGCGAGGAACCTTACCCGGGCTTGAATTGCAACTGAATGATGTGGAGACATGTCAGCCGCAAGGCAGTTGTGAAGGTGCTGCATGGTTGTCGTCAGCTCGTGCCGTGAGGTGTCGGCTTAAGTGCCATAACGAGCGCAACCCTTATCGATAGTTACCATCAGGTTATGCTGGGGACTCTGTCGAGACTGCCGTCGTAAGATGTGAGGAAGGTGGGGATGACGTCAAATCAGCACGGCCCTTACGTCCGGGGCTACACACGTGTTACAATGGGGGGTACAGAAGGCAGCTACACGGCGACGTGATGCTAATCCCGAAAGCCTCTCTCAGTTCGGATTGGAGTCTGCAACCCGACTCCATGAAGCTGGATTCGCTAGTAATCGCGCATCAGCCACGGCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCAAGCCATGAAAGCCGGGGGTACCTGAAGTGCGTAACCGCAAGGAGCGCCCTAGGGTAAAACTGGTGACTGGGGCTAAG
Embodiment 2 bacteroides uniformis L8 is to the Degradation of agaropectin oligose
AO in VI-AO liquid nutrient medium in embodiment 1 is replaced with respectively the agaropectin oligose (molecular-weight average 0.5 ~ 10kDa) of final concentration 1g/L, 30g/L and 50g/L, obtain VI-AO-1, VI-AO-30 and VI-AO-50 substratum.Slant medium is the agar powder adding final concentration 1.5wt% in embodiment 1 in VI-AO liquid nutrient medium, and seed liquor substratum is VI-AO liquid nutrient medium in embodiment 1.
Bacteroides uniformis L8 is seeded to slant medium, cultivates 3 days for 37 DEG C, obtain inclined-plane thalline; Mono-clonal is chosen to seed liquor substratum from inclined-plane thalline, cultivate 3 days for 37 DEG C, obtain seed liquor, seed liquor is seeded to VI-AO-1 respectively with 6% volume ratio, VI-AO-30 and VI-AO-50 liquid nutrient medium, at 37 DEG C of Anaerobic culturel, be cultured to 48h, 96h, 144h, 192h sampling respectively, analyze degraded situation, degraded product structure and degradation capability.
(1) degraded situation analysis
Adopt thin layer chromatography method (method is with embodiment 1 step (5)) to detect bacteroides uniformis L8 to the degraded of 1g/L, 30g/L and 50g/LAO, concrete degraded situation is in table 2, and as shown in Table 2, bacteroides uniformis L8 can degrade the AO within the scope of 1 ~ 50g/L.
Table 2B.uniformisL8 is to the degraded situation of different concns AO
AO concentration (g/L) | Whether degrade |
1 | Degraded |
30 | Degraded |
50 | Degraded |
(2) HPLC analyzes the structure of degraded end product
Get the 100 μ L bacteroides uniformis L8 fermented liquid that fermentation culture 192h obtains in the VI-AO liquid nutrient medium of AO final concentration 30g/L, adopt (the concrete grammar reference: pay Haining etc. of 1-phenyl-3-methyl-5-pyrazolones ketone (PMP) pre-column derivatization-high performance liquid chromatography monose composition, four kinds of chromatographic processes of fucoidin monosaccharide composition analysis compare, Chinese Sea medicine, 2008,27 (4): 30).By with the contrasting of monose standard substance (seminose, rhamnosyl, galacturonic acid, glucose, semi-lactosi, wood sugar) retention time, determine that final degraded product is D-semi-lactosi (see Fig. 2), molecular weight is 180Da.
(3) residue AO content after Phenol-sulphate acid method analysis degraded
The standard D-semi-lactosi aqueous solution of accurate preparation 0.5mg/mL, accurate absorption 10,20,30,40,50 μ L, add water and mend to 100 μ L, add 6%(W/V) phenol 200 μ L, add the vitriol oil (mass concentration 98%) 1.5mL fast, vibration shakes up, 100 DEG C of heating in water bath 10min, surveys absorbancy after cooling at 490nm.Operate as blank using 100 μ L distilled water by same, using D-semi-lactosi quality as X-coordinate, absorbancy draws D-semi-lactosi typical curve as ordinate zou, and regression equation is y=0.0157x+0.0115(R
2=0.9991), x is D-semi-lactosi quality, and y is light absorption value.
Get the operation of the 100 μ L bacteroides uniformis L8 fermented liquid centrifuging and taking 40 μ L supernatant liquor that fermentation culture 192h obtains in the VI-AO liquid nutrient medium of AO final concentration 30g/L by D-semi-lactosi typical curve, 490nm detects absorbancy, with D-semi-lactosi typical curve regression equation calculation fermented liquid total sugar content.As calculated, remaining AO content in fermented liquid is 3.25g/L, and prove that bacteroides uniformis L8 can degrade AO, degradation rate is 89%.
Embodiment 3 bacteroides uniformis L8 is to the Degradation of agar-agar (AP)
It is 100 ~ 300kDa that the AO of VI-AO liquid nutrient medium in embodiment 1 is replaced to AP(molecular weight), in substratum, the final concentration of AP is respectively 0.5g/L and 1g/L, preparation VI-AP-0.5 and VI-AP-1 liquid nutrient medium.Slant medium is the agar powder adding final concentration 1.5wt% in embodiment 1 in VI-AO liquid nutrient medium, and seed liquor substratum is VI-AO liquid nutrient medium in embodiment 1.
Bacteroides uniformis L8 is seeded to slant medium, cultivate 3 days for 37 DEG C, choose mono-clonal from inclined-plane thalline and be seeded to seed culture medium, cultivate 3 days for 37 DEG C, after obtaining seed liquor, seed liquor is seeded to VI-AP-0.5 liquid nutrient medium and VI-AP-1 liquid nutrient medium respectively with the inoculum size of volumetric concentration 6%, 37 DEG C of Anaerobic culturel, respectively at 0h, 48h, 96h, 144h and 192h sampling, analyze degraded situation, degraded product structure and degradation capability.
(1) degraded situation
Thin layer chromatography method is adopted to detect degraded situation, when in TLC display substratum, AP final concentration is 0.5g/L and 1g/L, B.uniformisL8 can degrade AP(table 3), Fig. 3 is the degraded situation of TLC when to analyze AP final concentration be 1g/L, after Fig. 3 shows reaction 48h, agar-agar is degraded to agaropectin oligose, and the laggard step-down solution of reaction 96h is to end product.
(2) HPLC analyzes the structure of degraded product
Get the VI-AP-1 liquid nutrient medium 192h fermented liquid that 100 μ l bacteroides uniformis L8 are 1g/L at AP final concentration, PMP-derivatization method in embodiment 2 is adopted to measure the structure of end product, by with the contrasting of monose standard substance (seminose, rhamnosyl, galacturonic acid, glucose, D-semi-lactosi, wood sugar) retention time, determine that final degraded product is D-semi-lactosi (Fig. 4).
(3) Phenol-sulphate acid method remains AP content after measuring L8 degraded
The making of D-semi-lactosi typical curve is with embodiment 2.
Get the 100 μ L bacteroides uniformis L8 fermented liquid that fermentation culture 192h obtains in the VI-AP-1 liquid nutrient medium of AP final concentration 1g/L by embodiment 2 method, 490nm detects absorbancy, with typical curve regression equation calculation total sugar content.As calculated, remaining AP content in fermented liquid is 0.3g/L, and prove that bacteroides uniformis L8 can degrade AP, degradation rate is 70%.
Table 3B.uniformisL8 is to the degraded situation of different concns AP
AP concentration (g/L) | Whether degrade |
0.5 | Degraded |
1.0 | Degraded |
Embodiment 4 agaropectin oligose promotes that B.uniformisL8 breeds in bottle fermentation
1. the preparation method of agaropectin oligose and molecular weight determination are with embodiment 1.
2. the preparation of substratum is with the preparation of VI-AO in embodiment 1.
3. the pre-treatment of ight soil
Get 3 volunteer's fresh excretas, treatment process, with embodiment 1, obtains ight soil PBS solution.
4. inoculation culture
Gained ight soil PBS solution is seeded to VI-AO liquid nutrient medium (inoculation volume final concentration is 2%) respectively, 37 DEG C of Anaerobic culturel, and respectively at 0h and 48h sampling, is numbered No.1, No.2 and No.3 respectively.
5. adopt QIAGEN ight soil test kit (Qiagen company, Germany) to extract the DNA of 0h and 48h fermented liquid and bacteroides uniformis L8.
6.RT-TimePCR compares the quantity of B.uniformisL8 in 0h and 48h fermented liquid
(1) Primer selection:
Adopt bibliographical information Bacteroidesuniformis special primer (EijiIshikawa etc., JBiosciBioeng.2013,116 (2): 265-70)
Buni188-F(TTCTTCCGCATGGTAGAAC),
Buni590-R(CTTTCACAACTGACTTAAGCG)
(2) amplification system: reaction system 25 μ L, DNA profiling 100ng(and BacteroidesuniformisL8DNA), 10 × PCRBuffer2.5 μ L, dNTPmix0.5 μ L, 10 μMs of each 0.5 μ L of upstream and downstream primer, Taq enzyme (5U/ μ L) 0.2 μ L, adds deionized water and complements to 25 μ L.
(3) amplification condition: denaturation 94 DEG C of 5mim, circulate 94 DEG C of 35S, 55 DEG C of 35S, 72 DEG C of 1min, 35 circulations, extends 8min.
(4) preparation of outer standard substance: the fragment that application specific primer Buni188-F and Buni590-R increases is carried out glue and reclaimed purifying after adopting electrophoresis detection, purified fragments is connected with pMD18-T carrier, be transformed in competent escherichia coli cell DH-5 α after connection, select positive colony order-checking, authenticated positive colony is extracted plasmid, adopt trace dna determinator NanoDrop2000(Thermo, USA), after measuring plasmid concentration, the concentration that substitution formula 1 calculates linearized plasmid solution is 2.94 × 10
8copy number/ng plasmid DNA (formula 1 namely: copy number=9.1 × 10 of every 1 μ g plasmid DNA
11the size (kb) of/plasmid DNA), plasmid deionized water extraction obtained, by 10 times of gradient dilutions, uses dilution rear 2.94 × 10
8-2.94 × 10
1copy number/ng plasmid DNA as the template of typical curve, for the quantitative assay of this Pseudomonas in subsequent sample.
(5) RT-TimePCR measures the quantity of B.uniformisL8 in ight soil and fermented liquid
Reaction conditions: the reaction system of 20 μ L, wherein: 2 × SYBRGreenRealtimePCRMasterMix (Toyobo, Japan) 10 μ L, each 0.5 μM of upstream and downstream primer, DNA profiling (being respectively extraction 0 and 48h fermented liquid DNA in the plasmid DNA of (4) gained typical curve concentration used in step 6, step 5) adds 20ng.
Response procedures: 95 DEG C of denaturation 1min; 95 DEG C of sex change 15s, 55 DEG C of 15s, 72 DEG C extend 15s, carry out 40 circulations altogether.
The typical curve of fluorescent quantitation is with the concentration of PCR reaction template (getting log value) for X-coordinate, the curve about template concentrations and CP value relation done for ordinate zou with CrossingPoint value (CP value).The equation Y=-4.079X+47.258(R of this curve
2=0.991), Y is CP value, and X is template concentrations.
Calculate in 0h and 48h fermented liquid according to typical curve that B.uniformisL8 quantity is in table 3, as can be seen from the table, in fermented liquid, B.uniformisL8 quantity is apparently higher than ight soil, illustrates that AO can promote the propagation of B.uniformisL8.
B.uniformisL8 quantity in table 3 ight soil and fermented liquid
Claims (7)
1. bacteroides uniformis (
bacteroidesuniformis) L8, be preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number is CGMCCNO.8711, preservation date is on January 10th, 2014, preservation address is No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, postcode 100101.
2. the application of bacteroides uniformis L8 described in claim 1 in degraded agar-agar or agaropectin oligose.
3. apply as claimed in claim 2, it is characterized in that described application method is: the seed liquor obtained after seed culture by bacteroides uniformis L8 is seeded in agar-agar or agaropectin oligose substratum with the inoculum size of volume ratio 2 ~ 10%, 25 ~ 42 DEG C of cultivations, thin layer chromatography tracing detection is reduced to less than 7 to polymerizable raw material degree, realizes the degraded of agar-agar or agaropectin oligose;
Described agar medium final concentration consists of: agar-agar 0.5 ~ 1g/L, Tryptones 3g/L, peptone 3g/L, yeast extract 4.5g/L, Saliva Orthana 0.5g/L, No. 3 cholate 0.4g/L, L-cysteine hydrochloride 0.8g/L, protoheme 0.05g/L, 1ml/L tween 80, NaCl4.5g/L, KCl2.5g/L, MgCl
26H
2o4.5g/L, CaCl
26H
2o0.2g/L, KH
2pO
40.4g/L, micro-2ml/L, solvent is distilled water, and pH value is 6.4 ~ 6.5; Described micro-final concentration consists of: MgSO
47H
2o3.0g/L, CaCl
22H
2o0.1g/L, MnCl
24H
2o0.32g/L, FeSO
47H
2o0.1g/L, CoSO
47H
2o0.18g/L, ZnSO
47H
2o0.18g/L, CuSO
45H
2o0.01g/L, NiCl
26H
2o0.092g/L;
Described agaropectin oligose substratum final concentration consists of: replaced by the 1 ~ 50g/L of the agar-agar in agar medium agaropectin oligose, other form same agar medium.
4. apply as claimed in claim 3, it is characterized in that described agar-agar molecular weight is 100 ~ 300kDa.
5. apply as claimed in claim 3, it is characterized in that described agaropectin oligose molecular weight is 0.5 ~ 10kDa, structure is G-[A-G]
n, n is positive integer, 1≤n≤31, and G represents D-semi-lactosi, and A represents 3,6-inner ether semi-lactosi.
6. apply as claimed in claim 3, it is characterized in that the seed liquor that described bacteroides uniformis L8 obtains after seed culture is inoculated with the inoculum size of volume ratio 4% ~ 6%.
7. apply as claimed in claim 3, it is characterized in that described being applied as:
(1) slant culture: bacteroides uniformis L8 is seeded to slant medium, cultivates 2 ~ 4 days for 25 ~ 42 DEG C, obtains inclined-plane thalline; Described slant medium is: in agaropectin oligose substratum, add the agar powder that quality final concentration is 1.5%;
(2) seed culture: be seeded to seed culture medium from inclined-plane thalline picking colony, cultivates 2 ~ 4 days for 25 ~ 42 DEG C, obtains seed liquor; Described seed culture medium is with agaropectin oligose substratum;
(3) fermentation culture: seed liquor is seeded in agar-agar or agaropectin oligose substratum with the inoculum size of volume ratio 4% ~ 6%, 25 ~ 42 DEG C of cultivations, thin layer chromatography tracing detection is reduced to less than 7 to polymerizable raw material degree, realizes the degraded of agar-agar or agaropectin oligose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410054976.7A CN103865844B (en) | 2014-02-18 | 2014-02-18 | Bacteroides uniformis L8 and the application in degraded agar-agar or agaropectin oligose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410054976.7A CN103865844B (en) | 2014-02-18 | 2014-02-18 | Bacteroides uniformis L8 and the application in degraded agar-agar or agaropectin oligose |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103865844A CN103865844A (en) | 2014-06-18 |
CN103865844B true CN103865844B (en) | 2015-12-09 |
Family
ID=50904856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410054976.7A Expired - Fee Related CN103865844B (en) | 2014-02-18 | 2014-02-18 | Bacteroides uniformis L8 and the application in degraded agar-agar or agaropectin oligose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103865844B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107002022A (en) * | 2014-09-30 | 2017-08-01 | 上海交通大学医学院附属瑞金医院 | Use of bacteroides in the treatment or prevention of obesity related diseases |
CN105106243A (en) * | 2015-08-03 | 2015-12-02 | 上海交通大学医学院附属瑞金医院 | Application of Bacteroides thetaiotaomicron VPI-5482 in preparation of medicines for treating or preventing obesity |
CN111714522B (en) * | 2019-03-04 | 2022-07-15 | 中国科学院微生物研究所 | Bacteroides and application thereof |
CN116676207B (en) * | 2023-03-14 | 2024-06-04 | 中国海洋大学 | Bacteroides sally strain and application thereof in degradation preparation of chondroitin sulfate oligosaccharide and hyaluronic acid oligosaccharide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796676A (en) * | 2011-05-26 | 2012-11-28 | 北京大学 | Bacteroides uniformis Strain-I and application thereof |
WO2013175038A1 (en) * | 2012-05-25 | 2013-11-28 | Consejo Superior De Investigaciones Científicas (Csic) | Bacteroides cect 7771 and the use thereof in the prevention and treatment of excess weight, obesity and metabolic and immunological alterations |
-
2014
- 2014-02-18 CN CN201410054976.7A patent/CN103865844B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796676A (en) * | 2011-05-26 | 2012-11-28 | 北京大学 | Bacteroides uniformis Strain-I and application thereof |
WO2013175038A1 (en) * | 2012-05-25 | 2013-11-28 | Consejo Superior De Investigaciones Científicas (Csic) | Bacteroides cect 7771 and the use thereof in the prevention and treatment of excess weight, obesity and metabolic and immunological alterations |
Non-Patent Citations (2)
Title |
---|
4株琼胶降解菌的分离、鉴定及产酶条件分析;牟宗娟等;《海洋科学》;20131231;13-20 * |
琼胶酶的研究进展;李能章等;《生命科学研究》;20060630;62-66 * |
Also Published As
Publication number | Publication date |
---|---|
CN103865844A (en) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jin et al. | Isolation and characterization of high exopolysaccharide-producing Weissella confusa VP30 from young children’s feces | |
CN102191192B (en) | Animal Bifidobacterium and use method thereof | |
Hartanti et al. | Rhizopus species from fresh tempeh collected from several regions in Indonesia | |
Li et al. | The influence of fermentation condition on production and molecular mass of EPS produced by Streptococcus thermophilus 05-34 in milk-based medium | |
CN103421715B (en) | Lactobacillus rhamnosus and application thereof | |
CN103865844B (en) | Bacteroides uniformis L8 and the application in degraded agar-agar or agaropectin oligose | |
CN104928208B (en) | Lactobacillus plantarum Lp90, and screening method and application thereof | |
CN107384828B (en) | Ackermanella myxobacteria culture medium and preparation method thereof | |
Mao et al. | Effect of disodium fumarate on ruminal metabolism and rumen bacterial communities as revealed by denaturing gradient gel electrophoresis analysis of 16S ribosomal DNA | |
CN105175518B (en) | The bacteriocin and preparation method thereof that bacillus coagulans FM603 is generated | |
CN110564638A (en) | Lactobacillus reuteri with probiotic characteristics and application thereof | |
CN106957810A (en) | A kind of Pediococcus acidilactici and application thereof | |
CN109423465A (en) | A kind of control aflatoxin B1Composite biological agent and its application | |
CN109679882A (en) | One Enterococcus faecalis DT1-1 and its application | |
CN104277999A (en) | Novel multiple-effect Clostridium butyricum and application thereof in aspects of enhancing oxidation resistance of animals and improving meat quality | |
CN104232520A (en) | Preparation method and application of lactobacillus plantarum and bacteriocin of lactobacillus plantarum | |
CN100368530C (en) | Bifidobacteria exocellular polysaccharide and its production method and special purpose production strain | |
CN105925499A (en) | Pediococcus acidilactici JQQ2 and applications thereof | |
CN103695343B (en) | One strain utilize arginine and do not accumulate citrulline addicted to salt tetrads | |
CN105661230A (en) | Probiotic functional beverage and probiotic food prepared from Lens culinaris by fermentation | |
CN104248646A (en) | Preparation method of fungus sporophore fermented by lactic acid bacteria | |
CN104031862A (en) | High-yield gamma-aminobutyric acid (GABA) strain and application thereof | |
Zhang et al. | Influence of casein hydrolysates on exopolysaccharide synthesis by Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus | |
Marrero et al. | Identification of Levica yeasts as a potential ruminal microbial additive. | |
CN105039202A (en) | Selective medium for multiplex proliferation of salmonella, listeria monocytogenes and vibrio parahaemolyticus and preparation method of selective medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151209 |